Generali Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
VCM
VPM
DAM
Generali Asset Management's RMD Position: Q1 2026 in Review
Generali Asset Management increased its ResMed (RMD) stake by 34% in Q1 2026, buying an estimated $587K and bringing the position to 9,191 shares worth $2.06M. The position accounts for 0.04% of the portfolio, ranked #289.
Generali Asset Management first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.2M in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Generali Asset Management held 9,191 shares of ResMed worth $2.06M as of Q1 2026.
- Generali Asset Management bought 2,357 ResMed shares in Q1 2026, an estimated $587K.
- ResMed made up 0.04% of Generali Asset Management's portfolio in Q1 2026, its #289 holding.
- Generali Asset Management first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
- Generali Asset Management's ResMed position peaked at $4.2M in Q4 2024.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.